Relmada Therapeutics Inc banner

Relmada Therapeutics Inc
NASDAQ:RLMD

Watchlist Manager
Relmada Therapeutics Inc Logo
Relmada Therapeutics Inc
NASDAQ:RLMD
Watchlist
Price: 3.6 USD -1.37% Market Closed
Market Cap: $264m

Balance Sheet

Balance Sheet Decomposition
Relmada Therapeutics Inc

Balance Sheet
Relmada Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
36
3
44
5
4
4
Cash Equivalents
36
3
44
5
4
4
Short-Term Investments
80
115
168
143
92
41
Total Receivables
0
0
0
1
0
0
Other Current Assets
0
1
11
4
1
1
Total Current Assets
117
118
223
153
98
46
PP&E Net
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
Total Assets
117
N/A
118
+1%
223
+89%
153
-32%
98
-36%
46
-53%
Liabilities
Accounts Payable
1
8
11
5
4
4
Accrued Liabilities
1
4
4
7
9
6
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
Total Current Liabilities
2
13
15
13
12
10
Long-Term Debt
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
Total Liabilities
2
N/A
13
+740%
15
+20%
13
-17%
12
-2%
10
-16%
Equity
Common Stock
0
0
0
0
0
0
Retained Earnings
120
179
305
462
561
641
Additional Paid In Capital
236
285
513
603
646
676
Total Equity
116
N/A
106
-9%
208
+97%
140
-33%
85
-39%
36
-58%
Total Liabilities & Equity
117
N/A
118
+1%
223
+89%
153
-32%
98
-36%
46
-53%
Shares Outstanding
Common Shares Outstanding
15
16
28
30
30
30
Preferred Shares Outstanding
0
0
0
0
0
0